Regulation of P-glycoprotein by human immunodeficiency virus-1 in primary cultures of human fetal astrocytes

Journal of Neuroscience Research

Volumn 89, Issue 11, 2011, Pages 1773-1782

  Ashraf, Tamima ^a   Ronaldson, Patrick T ^a,b   Persidsky, Yuri ^c   Bendayan, Reina ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Astrocyte; Gp120; HIV 1; Inflammation; Interleukin 6; NF B; P glycoprotein

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; DARUNAVIR; DIGOXIN; GLYCOPROTEIN GP 120; GLYCOPROTEIN P; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SN 50; TUMOR NECROSIS FACTOR ALPHA; VIRUS PROTEIN;

ARTICLE; ASTROCYTE; CELL CULTURE; CONTROLLED STUDY; DRUG ACCUMULATION; FETUS; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IN VITRO STUDY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRUS ISOLATION;

ASTROCYTES; CELLS, CULTURED; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; NF-KAPPA B; P-GLYCOPROTEIN; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 80052618777     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22720     Document Type: Article

References (46)

1. Alexaki A, Liu Y, Wigdahl B. 2008. Cellular reservoirs of HIV-1 and their role in viral persistence. Curr HIV Res 6: 388-400.
2. Ances BM, Ellis RJ. 2007. Dementia and neurocognitive disorders due to HIV-1 infection. Semin Neurol 27: 86-92.
3. Bauer B, Hartz AM, Miller DS. 2007. Tumor necrosis factor alpha and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier. Mol Pharmacol 71: 667-675.
4. Bendayan R, Lee G, Bendayan M. 2002. Functional expression and localization of P-glycoprotein at the blood-brain barrier. Microsc Res Techniq 57: 365-380.
5. Bendayan R, Ronaldson PT, Gingras D, Bendayan M. 2006. In situ localization of P-glycoprotein (ABCB1) in human and rat brain. J Histochem Cytochem 54: 1159-1167.
6. Boutet A, Salim H, Taoufik Y, Lledo PM, Vincent JD, Delfraissy JF, Tardieu M. 2001. Isolated human astrocytes are not susceptible to infection by M- and T-tropic HIV-1 strains despite functional expression of the chemokine receptors CCR5 and CXCR4. Glia 34: 165-177.
7. Chan GN, Tozammel HM, Cummins CL, Bendayan R. 2011. Regulation of P-glycoprotein by orphan nuclear receptors in human brain microvessel endothelial cells. J Neurochem 10: 4159.
8. Chandler B, Almond L, Ford J, Owen A, Hoggard P, Khoo S, Back D. 2003. The effects of protease inhibitors and nonnucleoside reverse transcriptase inhibitors on p-glycoprotein expression in peripheral blood mononuclear cells in vitro. J Acquir Immune Defic Syndr 33: 551-556.
9. Dallas S, Ronaldson PT, Bendayan M, Bendayan R. 2004. Multidrug resistance protein 1-mediated transport of saquinavir by microglia. Neuroreport 19: 1183-1186.
10. Gadient RA, Otten UH. 1997. Interleukin-6 (IL-6)-a molecule with both beneficial and destructive potentials. Prog Neurobiol 52: 379-390.
11. Gollapudi S, Gupta S. 1990. Human immunodeficiency virus I-induced expression of P-glycoprotein. Biochem Biophys Res Commun 171: 1002-1007.
12. Gorry PR, Ong C, Thorpe J, Bannwarth S, Thompson KA, Gatignol A, Vesselingh SL, Purcell DF. 2003. Astrocyte infection by HIV-1: mechanisms of restricted virus replication, and role in the pathogenesis of HIV-1-associated dementia. Curr HIV Res 1: 463-473.
13. Hammond RR, Iskander S, Achim CL, Hearn S, Nassif J, Wiley CA. 2002. A reliable primary human CNS culture protocol for morphological studies of dendritic and synaptic elements. J Neurosci Methods 118: 189-198.
14. Hayashi K, Pu H, Tian J, Andras IE, Lee YW, Hennig B, Toborek M. 2005. HIV-Tat protein induces P-glycoprotein expression in brain microvascular endothelial cells. J Neurochem 93: 1231-1241.
15. Kaul M. 2009. HIV-1 associated dementia: update on pathological mechanisms and therapeutic approaches. Curr Opin Neurol 22: 315-320.
16. Kaul M, Lipton SA. 2006. Mechanisms of neuroimmunity and neurodegeneration associated with HIV-1 infection and AIDS. J Neuroimmune Pharmacol 1: 138-151.
17. Kaul M, Zheng J, Okamoto S, Gendelman HE, Lipton SA. 2005. HIV-1 infection and AIDS: consequences for the central nervous system. Cell Death Differ 12( Suppl 1): 878-892.
18. Kis O, Robillard K, Chan GN, Bendayan R. 2010. The complexities of antiretroviral drug-drug interactions: role of ABC and SLC transporters. Trends Pharmacol Sci 31: 22-35.
19. Langford D, Grigorian A, Hurford R, Adame A, Ellis RJ, Hansen L, Masliah E. 2004. Altered P-glycoprotein expression in AIDS patients with HIV encephalitis. J Neuropathol Exp Neurol 63: 1038-1047.
20. Lee G, Piquette-Miller M. 2001. Influence of IL-6 on MDR and MRP-mediated multidrug resistance in human hepatoma cells. Can J Physiol Pharmacol 79: 876-884.
21. Lee G, Dallas S, Hong M, Bendayan R. 2001a. Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations. Pharmacol Rev 53: 569-596.
22. Lee G, Schlichter L, Bendayan M, Bendayan R. 2001b. Functional expression of P-glycoprotein in rat brain microglia. J Pharmacol Exp Ther 299: 204-212.
23. Lee SC, Liu W, Dickson DW, Brosnan CF, Berman JW. 1993. Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta. J Immunol 150: 2659-2667.
24. Liu Y, Liu H, Kim BO, Gattone VH, Li J, Nath A, Blum J, He JJ. 2004. CD4-independent infection of astrocytes by human immunodeficiency virus type 1: requirement for the human mannose receptor. J Virol 78: 4120-4133.
25. Mahlknecht U, Dichamp I, Varin A, Van LC, Herbein G. 2008. NF-kappaB-dependent control of HIV-1 transcription by the second coding exon of Tat in T cells. J Leukoc Biol 83: 718-727.
26. Persidsky Y, Gendelman HE. 2003. Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection. J Leukoc Biol 74: 691-701.
27. Persidsky Y, Buttini M, Limoges J, Bock P, Gendelman HE. 1997. An analysis of HIV-1-associated inflammatory products in brain tissue of humans and SCID mice with HIV-1 encephalitis. J Neurovirol 3: 401-416.
28. Persidsky Y, Ghorpade A, Rasmussen J, Limoges J, Liu XJ, Stins M, Fiala M, Way D, Kim KS, Witte MH, Weinand M, Carhart L, Gendelman HE. 1999. Microglial and astrocyte chemokines regulate monocyte migration through the blood-brain barrier in human immunodeficiency virus-1 encephalitis. Am J Pathol 155: 1599-1611.
29. Persidsky Y, Ramirez SH, Haorah J, Kanmogne GD. 2006. Blood-brain barrier: structural components and function under physiologic and pathologic conditions. J Neuroimmune Pharmacol 1: 223-236.
30. Poller B, Drewe J, Krahenbuhl S, Huwyler J, Gutmann H. 2010. Regulation of BCRP (ABCG2) and P-glycoprotein (ABCB1) by cytokines in a model of the human blood-brain barrier. Cell Mol Neurobiol 30: 63-70.
31. Ricardo-Dukelow M, Kadiu I, Rozek W, Schlautman J, Persidsky Y, Ciborowski P, Kanmogne GD, Gendelman HE. 2007. HIV-1 infected monocyte-derived macrophages affect the human brain microvascular endothelial cell proteome: new insights into blood-brain barrier dysfunction for HIV-1-associated dementia. J Neuroimmunol 185: 37-46.
32. Ronaldson PT, Bendayan R. 2006. HIV-1 viral envelope glycoprotein gp120 triggers an inflammatory response in cultured rat astrocytes and regulates the functional expression of P-glycoprotein. Mol Pharmacol 70: 1087-1098.
33. Ronaldson PT, Bendayan M, Gingras D, Piquette-Miller M, Bendayan R. 2004a. Cellular localization and functional expression of P-glycoprotein in rat astrocyte cultures. J Neurochem 89: 788-800.
34. Ronaldson PT, Lee G, Dallas S, Bendayan R. 2004b. Involvement of P-glycoprotein in the transport of saquinavir and indinavir in rat brain microvessel endothelial and microglia cell lines. Pharm Res 21: 811-818.
35. Ronaldson PT, Persidsky Y, Bendayan R. 2008. Regulation of ABC membrane transporters in glial cells: relevance to the pharmacotherapy of brain HIV-1 infection. Glia 56: 1711-1735.
36. Ronaldson PT, Ashraf T, Bendayan R. 2010. Regulation of multidrug resistance protein 1 by tumor necrosis factor alpha in cultured glial cells: involvement of nuclear factor-kappaB and c-Jun N-terminal kinase signaling pathways. Mol Pharmacol 77: 644-659.
37. Sabri F, Tresoldi E, Di SM, Polo S, Monaco MC, Verani A, Fiore JR, Lusso P, Major E, Chiodi F, Scarlatti G. 1999. Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors. Virology 264: 370-384.
38. Saha RN, Pahan K. 2007. Differential regulation of Mn-superoxide dismutase in neurons and astroglia by HIV-1 gp120: implications for HIV-associated dementia. Free Radic Biol Med 42: 1866-1878.
39. Salama NN, Kelly EJ, Bui T, Ho RJ. 2005. The impact of pharmacologic and genetic knockout of P-glycoprotein on nelfinavir levels in the brain and other tissues in mice. J Pharm Sci 94: 1216-1225.
40. Sluss HK, Barrett T, Derijard B, Davis RJ. 1994. Signal transduction by tumor necrosis factor mediated by JNK protein kinases. Mol Cell Biol 14: 8376-8384.
41. Spitzenberger TJ, Heilman D, Diekmann C, Batrakova EV, Kabanov AV, Gendelman HE, Elmquist WF, Persidsky Y. 2007. Novel delivery system enhances efficacy of antiretroviral therapy in animal model for HIV-1 encephalitis. J Cereb Blood Flow Metab 27: 1033-1042.
42. Sune C, Garcia-Blanco MA. 1995. Transcriptional trans activation by human immunodeficiency virus type 1 Tat requires specific coactivators that are not basal factors. J Virol 69: 3098-3107.
43. Toggas SM, Masliah E, Rockenstein EM, Rall GF, Abraham CR, Mucke L. 1994. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367: 188-193.
44. Wu L, LaRosa G, Kassam N, Gordon CJ, Heath H, Ruffing N, Chen H, Humblias J, Samson M, Parmentier M, Moore JP, Mackay CR. 1997. Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding. J Exp Med 186: 1373-1381.
45. Yu C, Argyropoulos G, Zhang Y, Kastin AJ, Hsuchou H, Pan W. 2008. Neuroinflammation activates Mdr1b efflux transport through NFkappaB: promoter analysis in BBB endothelia. Cell Physiol Biochem 22: 745-756.
46. Zastre JA, Chan GN, Ronaldson PT, Ramaswamy M, Couraud PO, Romero IA, Weksler B, Bendayan M, Bendayan R. 2009. Up-regulation of P-glycoprotein by HIV protease inhibitors in a human brain microvessel endothelial cell line. J Neurosci Res 87: 1023-1036.